ArticleFrontiers in pharmacology2026

A real-world pharmacovigilance study of FDA adverse event reporting system events for bictegravir/emtricitabine/tenofovir alafenamide.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.